chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Deltoid muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Deltoid muscle pain) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Deltoid muscle pain). At the time of the report, MYALGIA (Deltoid muscle pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication nor treatment provided
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced DIZZINESS (dizziness). At the time of the report, DIZZINESS (dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication nor treatment provided.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Diarrhoea, Headache, Hypotension, Myalgia
Clinical narrative: Diarrhoea; Body ache; Very low blood pressure; Head ache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhoea), MYALGIA (Body ache), HYPOTENSION (Very low blood pressure), HEADACHE (Head ache) and PYREXIA (Fever) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0BA21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 31-Dec-2020 and COVID-19 (a week later 31-DEC-2020, was diagnosed again with COVID-19 and was hospitalized.). Concomitant products included TOPIRAMATE (TOPAMAX) for Migraine.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced DIARRHOEA (Diarrhoea), MYALGIA (Body ache), HYPOTENSION (Very low blood pressure), HEADACHE (Head ache) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) for Fever and Headache, at an unspecified dose and frequency. At the time of the report, DIARRHOEA (Diarrhoea), MYALGIA (Body ache), HYPOTENSION (Very low blood pressure), HEADACHE (Head ache) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Dec-2020, COVID-19: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Diarrhoea; Body ache; Very low blood pressure; Head ache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhoea), MYALGIA (Body ache), HYPOTENSION (Very low blood pressure), HEADACHE (Head ache) and PYREXIA (Fever) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0BA21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 31-Dec-2020 and COVID-19 (a week later 31-DEC-2020, was diagnosed again with COVID-19 and was hospitalized.). Concomitant products included TOPIRAMATE (TOPAMAX) for Migraine.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced DIARRHOEA (Diarrhoea), MYALGIA (Body ache), HYPOTENSION (Very low blood pressure), HEADACHE (Head ache) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) for Fever and Headache, at an unspecified dose and frequency. At the time of the report, DIARRHOEA (Diarrhoea), MYALGIA (Body ache), HYPOTENSION (Very low blood pressure), HEADACHE (Head ache) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Dec-2020, COVID-19: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: vaccinated while pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (vaccinated while pregnant) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 011J20A) for COVID-19 vaccination.     no medical history provided.  The patient's past medical history included Pre-eclampsia (In her previous pregnancy in 2018). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 08-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (vaccinated while pregnant). At the time of the report, EXPOSURE DURING PREGNANCY (vaccinated while pregnant) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No treatment information provided
Age: 70.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Body temperature increased, Headache, Influenza like illness, Lethargy, Lymphadenopathy
Clinical narrative: felt like she had the flu; lethargic; worst body aches; temperature peaked at 100.8° F; enlarged lymph node on her left armpit; severe headaches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (severe headaches), MYALGIA (worst body aches), BODY TEMPERATURE INCREASED (temperature peaked at 100.8° F), LETHARGY (lethargic) and INFLUENZA LIKE ILLNESS (felt like she had the flu) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product PARACETAMOL (TYLENOL) for Headache, Myalgia, Fever, Flu and Lymph nodes enlarged.    The patient's past medical history included Blood pressure, Thyroid disorder, Acid reflux (esophageal) and Cholesterol. Concomitant products included ACETYLSALICYLIC ACID (ASPRIN) for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient started PARACETAMOL (TYLENOL) (unknown route) at an unspecified dose. On 04-Mar-2021, the patient experienced HEADACHE (severe headaches). On 05-Mar-2021, the patient experienced MYALGIA (worst body aches), BODY TEMPERATURE INCREASED (temperature peaked at 100.8° F) and LYMPHADENOPATHY (enlarged lymph node on her left armpit). On 06-Mar-2021, the patient experienced LETHARGY (lethargic). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (felt like she had the flu). On 04-Mar-2021, HEADACHE (severe headaches) had resolved. On 05-Mar-2021, MYALGIA (worst body aches) and BODY TEMPERATURE INCREASED (temperature peaked at 100.8° F) had resolved. On 06-Mar-2021, LETHARGY (lethargic), INFLUENZA LIKE ILLNESS (felt like she had the flu) and LYMPHADENOPATHY (enlarged lymph node on her left armpit) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient mentioned ,she had a very mild symptoms of covid-19  in mid of October. Patient states she is taking concomitant medication for blood pressure, thyroid, acid reflux and cholesterol.
Age: 70.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Myalgia
Clinical narrative: felt like she had the flu; lethargic; worst body aches; temperature peaked at 100.8° F; enlarged lymph node on her left armpit; severe headaches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (severe headaches), MYALGIA (worst body aches), BODY TEMPERATURE INCREASED (temperature peaked at 100.8° F), LETHARGY (lethargic) and INFLUENZA LIKE ILLNESS (felt like she had the flu) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product PARACETAMOL (TYLENOL) for Headache, Myalgia, Fever, Flu and Lymph nodes enlarged.    The patient's past medical history included Blood pressure, Thyroid disorder, Acid reflux (esophageal) and Cholesterol. Concomitant products included ACETYLSALICYLIC ACID (ASPRIN) for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient started PARACETAMOL (TYLENOL) (unknown route) at an unspecified dose. On 04-Mar-2021, the patient experienced HEADACHE (severe headaches). On 05-Mar-2021, the patient experienced MYALGIA (worst body aches), BODY TEMPERATURE INCREASED (temperature peaked at 100.8° F) and LYMPHADENOPATHY (enlarged lymph node on her left armpit). On 06-Mar-2021, the patient experienced LETHARGY (lethargic). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (felt like she had the flu). On 04-Mar-2021, HEADACHE (severe headaches) had resolved. On 05-Mar-2021, MYALGIA (worst body aches) and BODY TEMPERATURE INCREASED (temperature peaked at 100.8° F) had resolved. On 06-Mar-2021, LETHARGY (lethargic), INFLUENZA LIKE ILLNESS (felt like she had the flu) and LYMPHADENOPATHY (enlarged lymph node on her left armpit) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient mentioned ,she had a very mild symptoms of covid-19  in mid of October. Patient states she is taking concomitant medication for blood pressure, thyroid, acid reflux and cholesterol.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blood pressure measurement, Chills, Fatigue, Feeling hot
Clinical narrative: Light flu symptoms; Face and head were hot without fever; Blood pressure went up; Itchy rash at the injection site; Rash on back of hands which wasn't itchy; Dull headache; Nausea; Joint pain; Chills; Tired; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Light flu symptoms), FEELING HOT (Face and head were hot without fever), HYPERTENSION (Blood pressure went up), VACCINATION SITE PRURITUS (Itchy rash at the injection site) and RASH (Rash on back of hands which wasn't itchy) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis. Concomitant products included METFORMIN for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Light flu symptoms), FEELING HOT (Face and head were hot without fever), HYPERTENSION (Blood pressure went up), VACCINATION SITE PRURITUS (Itchy rash at the injection site), RASH (Rash on back of hands which wasn't itchy), HEADACHE (Dull headache), NAUSEA (Nausea), ARTHRALGIA (Joint pain), CHILLS (Chills) and FATIGUE (Tired). At the time of the report, INFLUENZA LIKE ILLNESS (Light flu symptoms), FEELING HOT (Face and head were hot without fever), HYPERTENSION (Blood pressure went up), VACCINATION SITE PRURITUS (Itchy rash at the injection site), RASH (Rash on back of hands which wasn't itchy), HEADACHE (Dull headache), NAUSEA (Nausea), CHILLS (Chills) and FATIGUE (Tired) had resolved and ARTHRALGIA (Joint pain) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Feb-2021, Blood pressure measurement: high (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypertension, Influenza like illness, Nausea, Rash
Clinical narrative: Light flu symptoms; Face and head were hot without fever; Blood pressure went up; Itchy rash at the injection site; Rash on back of hands which wasn't itchy; Dull headache; Nausea; Joint pain; Chills; Tired; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Light flu symptoms), FEELING HOT (Face and head were hot without fever), HYPERTENSION (Blood pressure went up), VACCINATION SITE PRURITUS (Itchy rash at the injection site) and RASH (Rash on back of hands which wasn't itchy) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis. Concomitant products included METFORMIN for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Light flu symptoms), FEELING HOT (Face and head were hot without fever), HYPERTENSION (Blood pressure went up), VACCINATION SITE PRURITUS (Itchy rash at the injection site), RASH (Rash on back of hands which wasn't itchy), HEADACHE (Dull headache), NAUSEA (Nausea), ARTHRALGIA (Joint pain), CHILLS (Chills) and FATIGUE (Tired). At the time of the report, INFLUENZA LIKE ILLNESS (Light flu symptoms), FEELING HOT (Face and head were hot without fever), HYPERTENSION (Blood pressure went up), VACCINATION SITE PRURITUS (Itchy rash at the injection site), RASH (Rash on back of hands which wasn't itchy), HEADACHE (Dull headache), NAUSEA (Nausea), CHILLS (Chills) and FATIGUE (Tired) had resolved and ARTHRALGIA (Joint pain) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Feb-2021, Blood pressure measurement: high (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: Light flu symptoms; Face and head were hot without fever; Blood pressure went up; Itchy rash at the injection site; Rash on back of hands which wasn't itchy; Dull headache; Nausea; Joint pain; Chills; Tired; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Light flu symptoms), FEELING HOT (Face and head were hot without fever), HYPERTENSION (Blood pressure went up), VACCINATION SITE PRURITUS (Itchy rash at the injection site) and RASH (Rash on back of hands which wasn't itchy) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis. Concomitant products included METFORMIN for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Light flu symptoms), FEELING HOT (Face and head were hot without fever), HYPERTENSION (Blood pressure went up), VACCINATION SITE PRURITUS (Itchy rash at the injection site), RASH (Rash on back of hands which wasn't itchy), HEADACHE (Dull headache), NAUSEA (Nausea), ARTHRALGIA (Joint pain), CHILLS (Chills) and FATIGUE (Tired). At the time of the report, INFLUENZA LIKE ILLNESS (Light flu symptoms), FEELING HOT (Face and head were hot without fever), HYPERTENSION (Blood pressure went up), VACCINATION SITE PRURITUS (Itchy rash at the injection site), RASH (Rash on back of hands which wasn't itchy), HEADACHE (Dull headache), NAUSEA (Nausea), CHILLS (Chills) and FATIGUE (Tired) had resolved and ARTHRALGIA (Joint pain) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Feb-2021, Blood pressure measurement: high (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis, Headache
Clinical narrative: Bloody nose; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (Bloody nose) and HEADACHE (Headaches) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced EPISTAXIS (Bloody nose) and HEADACHE (Headaches). At the time of the report, EPISTAXIS (Bloody nose) and HEADACHE (Headaches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided. No treatment medication information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Patient missed 2nd Vaccination; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient missed 2nd Vaccination) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient missed 2nd Vaccination). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient missed 2nd Vaccination) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Inflammation, Pyrexia, Vaccination site pain, X-ray
Clinical narrative: Fever; arm pain; legs went numb; inflammation in the head,spine; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced fever, arm pain, legs went numb, inflammation in the head, and spine from the X-ray result.  The patient's medical history provided included MS. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route for prophylaxis of COVID-19 infection.  On unknown date, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route for prophylaxis of COVID-19 infection.  On an unknown date after the second dose, the patient experienced fever, arm pain,leg numbness, inflammation in head and  spine. On an unknown date, the lab test performed included X-Ray (inflammation in the head, and spine from the X-ray result)  Treatment details included Solu-Medro.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of events- fever, arm pain, legs went numb, inflammation in the head, and spine from the X-ray result -was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Malaise
Clinical narrative: diarrhea; does not feel good; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) and MALAISE (does not feel good) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No medical  history is provided and concomitant drugs are provided,.     On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea) and MALAISE (does not feel good). At the time of the report, DIARRHOEA (diarrhea) and MALAISE (does not feel good) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort
Clinical narrative: Experiencing IBS symptoms/stomach bothering me; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced IBS symptoms/stomach discomfort.  The patient's medical history was not provided. Concomitant medications reported were nexium (for unknown indication).  On 8 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: not provided) intramuscularly for prophylaxis of COVID-19 infection.   On 8 Mar 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: not provided) intramuscularly for prophylaxis of COVID-19 infection.  On 08 Mar 2021, the patient experienced IBS symptoms. Stomach was bothering her.  Treatment details included none.  Action taken with mRNA-1273 in response to the events was Unknown.  The outcome of event- experiencing IBS symptoms-  was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Chest discomfort, Dizziness, Pyrexia
Clinical narrative: dizziness; Weakness; tight chest; temperature 99.8°F; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), ASTHENIA (Weakness), CHEST DISCOMFORT (tight chest) and PYREXIA (temperature 99.8°F) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness), ASTHENIA (Weakness), CHEST DISCOMFORT (tight chest) and PYREXIA (temperature 99.8°F). At the time of the report, DIZZINESS (dizziness), ASTHENIA (Weakness), CHEST DISCOMFORT (tight chest) and PYREXIA (temperature 99.8°F) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, Body temperature: (High) 99.8 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        No relevant concomitant medications were reported. No treatment information was provided.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Tremendous leg pain and thighs pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Tremendous leg pain and thighs pain) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. C10M20A) for COVID-19 vaccination.     NO Medical History Information was reported.     On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced PAIN IN EXTREMITY (Tremendous leg pain and thighs pain). The patient was treated with TRAMADOL for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Tremendous leg pain and thighs pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-Feb-2021 and was forwarded to Moderna on 08-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Tremendous leg pain and thighs pain) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. C10M20A) for COVID-19 vaccination.     NO Medical History Information was reported.     On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced PAIN IN EXTREMITY (Tremendous leg pain and thighs pain). The patient was treated with TRAMADOL for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Tremendous leg pain and thighs pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Joint stiffness, Nausea, Paraesthesia
Clinical narrative: Stiffness in joints, legs and hands; Tingling in hands; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of JOINT STIFFNESS (Stiffness in joints, legs and hands), PARAESTHESIA (Tingling in hands) and NAUSEA (Nausea) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 047576) for COVID-19 vaccination.     Concurrent medical conditions included Asthma since 06-Jun-1975, Lupus erythematosus (IV REMISSION Skin Lupus) since 07-Feb-1989, Drug allergy and Drug allergy (Codeine). Concomitant products included MONTELUKAST SODIUM (SINGULAIR) from 10-Jul-1991 to an unknown date for Asthma, ESCITALOPRAM OXALATE (LEXAPRO) for Depression, MELATONIN from 20-Jan-2020 to an unknown date for Sleeplessness, LEVOTHYROXINE from 08-Mar-1980 to an unknown date for Thyroid disorder.   On 17-Jan-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021 at 1:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced JOINT STIFFNESS (Stiffness in joints, legs and hands), PARAESTHESIA (Tingling in hands) and NAUSEA (Nausea). At the time of the report, JOINT STIFFNESS (Stiffness in joints, legs and hands) had not resolved and PARAESTHESIA (Tingling in hands) and NAUSEA (Nausea) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were reported as Senna. The treatment information was unknown.   This case was linked to MOD-2021-281225 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Significant followup appended, Suspect details for second dose updated. On 09-Aug-2021: Follow up received and contain non significant information
Age: 74.0
Sex: U
Vaccine: COVID19
Symptoms: Pain, Pruritus
Clinical narrative: itching; pain; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of PAIN (pain) and PRURITUS (itching) in a 74-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included Pain.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN (pain). On 23-Feb-2021, the patient experienced PRURITUS (itching). On 25-Feb-2021, PRURITUS (itching) had resolved. At the time of the report, PAIN (pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included : steroid cream  No concomitant medications were reported
Sex: U
Vaccine: COVID19
Symptoms: Illness, Pyrexia
Clinical narrative: Ill; Temperature; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Ill) and PYREXIA (Temperature) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Ill) and PYREXIA (Temperature). At the time of the report, ILLNESS (Ill) and PYREXIA (Temperature) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported  Treatment details not  included.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Rash erythematous
Clinical narrative: Tingling right arm; red mark appearance; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (red mark appearance) and PARAESTHESIA (Tingling right arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH ERYTHEMATOUS (red mark appearance). On 07-Mar-2021, the patient experienced PARAESTHESIA (Tingling right arm). At the time of the report, RASH ERYTHEMATOUS (red mark appearance) and PARAESTHESIA (Tingling right arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported Treatment details included Tylenol.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Pain in extremity
Clinical narrative: nausea; headache; arm sore; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm sore), FATIGUE (fatigue), NAUSEA (nausea) and HEADACHE (headache) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included LOSARTAN and LEVOTHYROXINE for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm sore) and FATIGUE (fatigue). On 26-Feb-2021, the patient experienced NAUSEA (nausea) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 26-Feb-2021, PAIN IN EXTREMITY (arm sore) and FATIGUE (fatigue) had resolved. At the time of the report, NAUSEA (nausea) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain in extremity
Clinical narrative: pain in the arm; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the arm), CHILLS (chills) and FATIGUE (fatigue) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in the arm), CHILLS (chills) and FATIGUE (fatigue). At the time of the report, PAIN IN EXTREMITY (pain in the arm), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: chest pain; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced CHEST PAIN (chest pain). At the time of the report, CHEST PAIN (chest pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-037079 (Patient Link).
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity
Clinical narrative: Arm has a bit soreness; Redness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm has a bit soreness) and ERYTHEMA (Redness) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm has a bit soreness) and ERYTHEMA (Redness). At the time of the report, PAIN IN EXTREMITY (Arm has a bit soreness) and ERYTHEMA (Redness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tired) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced FATIGUE (tired). At the time of the report, FATIGUE (tired) outcome was unknown.            No concomitant medications and treatment was provided.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: rash on legs; welts on legs; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on legs) and URTICARIA (welts on legs) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced RASH (rash on legs) and URTICARIA (welts on legs). The patient was treated with PREDNISONE at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, RASH (rash on legs) and URTICARIA (welts on legs) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included METOPROLOL, ACETYLSALICYLIC ACID (ASPIRIN 81) and VITAMINS NOS for an unknown indication.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced DIARRHOEA (Diarrhea). On 08-Mar-2021, DIARRHOEA (Diarrhea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: sore arm; Fever; headache; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), PYREXIA (Fever), HEADACHE (headache) and MYALGIA (muscle aches) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038K20A and 048A121A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm), PYREXIA (Fever), HEADACHE (headache) and MYALGIA (muscle aches). On 07-Mar-2021, PYREXIA (Fever) had resolved. At the time of the report, PAIN IN EXTREMITY (sore arm), HEADACHE (headache) and MYALGIA (muscle aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Mar-2021, Body temperature: 101.2 (High) 101.2.         No corrective treatment was reported
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Scab, Vaccination site erythema
Clinical narrative: ring of red; redness measured 2 inches wide and 3 1/2 inches long; scab; This spontaneous case was reported by a consumer and describes the occurrence of SCAB (scab), ERYTHEMA (ring of red) and VACCINATION SITE ERYTHEMA (redness measured 2 inches wide and 3 1/2 inches long) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00A4212) for COVID-19 vaccination.     The patient's past medical history included Tuberculosis (being interned for 4 1/2 years.), Pregnancy (Patient had four pregnancies with no issues) and Venous ligation. Concomitant products included CETIRIZINE HYDROCHLORIDE, METOPROLOL, RALOXIFENE, APIXABAN (ELIQUIS) and ATORVASTATIN CALCIUM (STATIN [ATORVASTATIN CALCIUM]) for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced SCAB (scab). On 04-Mar-2021, the patient experienced ERYTHEMA (ring of red) and VACCINATION SITE ERYTHEMA (redness measured 2 inches wide and 3 1/2 inches long). At the time of the report, SCAB (scab), ERYTHEMA (ring of red) and VACCINATION SITE ERYTHEMA (redness measured 2 inches wide and 3 1/2 inches long) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient had her first administration of the Moderna COVID-19 Vaccine in her left non-dominant arm on 25Feb2021 without issue. While in the shower, sometime after receiving the vaccine, she pulled a scab from the injection site and the next day, on 04Mar21 or 05Mar21 she noticed a ring of red, reddish, not a rash, not itchy, ring around injection site. The redness measured 2 inches wide and 3 1/2 inches long. She reports that two days ago, on 06Mar2021, she applied cortisone but the red area hasn't gotten bigger and hasn't gotten smaller.  She plans on taking an allergy pill sometime today as she usually takes it when she has a reaction.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles on Right Arm; This spontaneous case was reported by a nurse and describes the occurrence of Shingles on Right Arm in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included Atherosclerosis. Concurrent medical conditions included Diabetes and Diabetes.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced Shingles on Right Arm. At the time of the report, Shingles on Right Arm outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia
Clinical narrative: Fatigue; Fever (Not Measured); This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) and PYREXIA (Fever (Not Measured)) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced FATIGUE (Fatigue) and PYREXIA (Fever (Not Measured)). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, FATIGUE (Fatigue) and PYREXIA (Fever (Not Measured)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pyrexia
Clinical narrative: Shivers; Low Grade Fever; Headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Shivers), PYREXIA (Low Grade Fever), HEADACHE (Headache) and FATIGUE (Fatigue) in a 92-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced CHILLS (Shivers), PYREXIA (Low Grade Fever), HEADACHE (Headache) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 19-Feb-2021, CHILLS (Shivers), PYREXIA (Low Grade Fever) and HEADACHE (Headache) had resolved. At the time of the report, FATIGUE (Fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no corrective treatment was received
Age: 71.0
Sex: U
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling, Pruritus, Skin discolouration
Clinical narrative: Right arm swelling; redness spreading; itching; black and blue color; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Right arm swelling), ERYTHEMA (redness spreading), PRURITUS (itching) and SKIN DISCOLOURATION (black and blue color) in a 71-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PERIPHERAL SWELLING (Right arm swelling), ERYTHEMA (redness spreading), PRURITUS (itching) and SKIN DISCOLOURATION (black and blue color). On 08-Mar-2021, PERIPHERAL SWELLING (Right arm swelling), PRURITUS (itching) and SKIN DISCOLOURATION (black and blue color) had resolved. At the time of the report, ERYTHEMA (redness spreading) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Oropharyngeal pain, Speech disorder
Clinical narrative: Patient got a sore throat 9 days after getting the first dose; Difficulty speaking; Patient developed a cough 9 days after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Patient got a sore throat 9 days after getting the first dose), SPEECH DISORDER (Difficulty speaking) and COUGH (Patient developed a cough 9 days after the first dose) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (Patient got a sore throat 9 days after getting the first dose), SPEECH DISORDER (Difficulty speaking) and COUGH (Patient developed a cough 9 days after the first dose). The patient was treated with CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]) at an unspecified dose and frequency. At the time of the report, OROPHARYNGEAL PAIN (Patient got a sore throat 9 days after getting the first dose), SPEECH DISORDER (Difficulty speaking) and COUGH (Patient developed a cough 9 days after the first dose) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication was reported.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Chills, Headache, Malaise
Clinical narrative: muscle aches; fever of 99.3; feeling very very sick; some weakness; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feeling very very sick), ASTHENIA (some weakness), CHILLS (chills), HEADACHE (headache) and MYALGIA (muscle aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced MALAISE (feeling very very sick), ASTHENIA (some weakness), CHILLS (chills), HEADACHE (headache) and PYREXIA (fever of 99.3). On an unknown date, the patient experienced MYALGIA (muscle aches). At the time of the report, MALAISE (feeling very very sick), ASTHENIA (some weakness), CHILLS (chills), HEADACHE (headache), MYALGIA (muscle aches) and PYREXIA (fever of 99.3) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Mar-2021, Body temperature: 99.3 (Inconclusive) 99.3.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by reporter. Treatment medication not reported. Action taken with mRNA-1273 was not applicable.